Evaluation of Nutritional Status, Eating Habits and Improvement of Symptoms With a Nutritional Intervention in Women With enDometriosis (ENDO-DIET)

May 10, 2023 updated by: Cinzia Ferraris, University of Pavia

Evaluation of Nutritional Status, Eating Habits and Improvement of Symptoms With a Nutritional Intervention in Women With enDometriosis and chrOnic Pelvic Pain

The study aims to investigate the nutritional status and eating habits of women suffering from endometriosis and chronic pelvic pain in relation to describe the possible improvement of clinical symptoms following a nutritional intervention.

The primary aim is to describe and evaluate the impact of nutritional intervention on clinical symptoms (pain, quality of life and intestinal function) in women suffering from endometriosis with chronic pelvic pain.

The first secondary aim will be to describe and evaluate the impact of the nutritional intervention by describing the changes in some specific areas of the patients (sexual, psychological) together with the quantification of some routine blood chemistry parameters (inflammatory markers, levels of proteins and vitamins) .

The second secondary objective will be aimed at describing the changes in clinical symptoms and the parameters mentioned above in patients based on the severity/stage of the pathologies under study.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

65

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Pavia, Italy, 27100
        • Recruiting
        • University of Pavia
        • Contact:
        • Principal Investigator:
          • Barbara Gardella, Dott.
        • Sub-Investigator:
          • Monica Guglielmetti, Dott.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

All patients referred to the Endometriosis Outpatient Clinic of the Gynecological Clinic of the San Matteo Polyclinic in Pavia will be enrolled and will agree to participate in the study and have signed the relative informed consent.

Description

Inclusion Criteria:

  • Clinical diagnosis of endometriosis +/- chronic pelvic pain
  • No menopause (at least 1 menstrual cycle in the previous 6 months)
  • Informed consent from the patient and / or an authorized legal representative

Exclusion Criteria:

  • Postmenopause
  • Pregnancy
  • Hysterectomy or oophorectomy
  • Chronic diseases that affect the gastrointestinal absorption of nutrients (celiac disease, Chron's disease, ulcerative colitis, cystic fibrosis)
  • History of kidney stones, cancer (except basal cell carcinoma) or diabetes
  • Modification in the course of the therapeutic intervention of the therapy for endometriosis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Observational group

A nutritional assessment will be held with the detection of anthropometric parameters. Each participant will be asked to fill in the SF36, the VAS scales, the KESS questionnaire, the SFFI questionnaire, the Questionnaire PUF and O'Leary/Santn, the BDI and the TAS for an assessment of the psychological component.

In addition, patients will be asked to fill in a FFQ of food consumption and a 7 days food diary. Finally, routine blood chemistry tests will also be performed, to which will be added those for measuring the inflammatory state and stool examination for the evaluation of fecal Calprotectin for the measurement of intestinal inflammatory markers.

The nutritional intervention will consist in providing general nutritional indications specific for endometriosis and an indicative daily diet plan, which must be followed for 6 months.

At the end of the 6 months, all anthropometric assessments, blood chemistry and stool tests will be repeated, together with the questionnaires.

The nutritional intervention will consist in providing general nutritional indications specific for endometriosis and an indicative ungrammatical daily diet plan, which must be followed for the entire period of intervention (6 months).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The primary outcome is to describe and evaluate the impact of nutritional intervention on clinical symptoms (pain, quality of life and intestinal function) in women suffering from endometriosis with chronic pelvic pain.
Time Frame: 6 months

The outcome will be assessed with repeated measurements using the following parameters:

-Evaluation of chronic pelvic pain, dysmenorrhea, dyschezia and dysuria: VAS visual analogue scale, from 0 to 10 points where 10 points indicates worst pain

6 months
The primary outcome is to describe and evaluate the impact of nutritional intervention on clinical symptoms (quality of life) in women suffering from endometriosis with chronic pelvic pain.
Time Frame: 6 months

The outcome will be assessed with repeated measurements using the following parameters:

Quality of life: measurement of physical and mental components with SF36 consisting of two components, one physical and one mental. Both fall within a range from 0 to 100 points where higher values are associated with better health

6 months
The primary outcome is to describe and evaluate the impact of nutritional intervention on clinical symptoms (intestinal function) in women suffering from endometriosis with chronic pelvic pain.
Time Frame: 6 months

The outcome will be assessed with repeated measurements using the following parameters:

Bowel Function: Knowles-Eccersley-Scott Symptom Questionnaire (KESS) (points)

6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The secondary outcome will be to describe and evaluate the impact of the nutritional intervention by describing the changes in Sexual Function
Time Frame: 6 months

The outcomes necessary to respond to the secondary objective are the administration of the following questionnaire:

Sexual Function: FSFI questionnaire (points)

6 months
To describe and evaluate the impact of the nutritional intervention by describing the changes in Urinary function and bladder pain
Time Frame: 6 months

The outcomes necessary to respond to the secondary objective are the administration of the following questionnaire:

Urinary function and bladder pain: PUF and O's Leary / Sant questionnaire (points)

6 months
The secondary outcome will be to describe and evaluate the impact of the nutritional intervention by describing the changes in Psychological component about Depression
Time Frame: 6 months

The outcomes necessary to respond to the secondary objective are the administration of the following questionnaire:

Beck Depression Inventory (BDI) (points)

6 months
The secondary outcome will be to describe and evaluate the impact of the nutritional intervention by describing the changes in Psychological component
Time Frame: 6 months

The outcomes necessary to respond to the secondary objective are the administration of the following questionnaires:

Alexithymia Scale (TAS) questionnaire (points)

6 months
The secondary outcome will be to describe and evaluate the impact of the nutritional intervention by describing the changes in some routine blood chemistry parameters
Time Frame: 6 months

The outcomes necessary to respond to the secondary objective are the administration of the following routine blood chemistry parameters:

Measure Ca125 (unità/ml) and Vitamin D (ng/ml)

6 months
The secondary outcome will be to describe and evaluate the impact of the nutritional intervention by describing the changes in Intestinal inflammatory marker
Time Frame: 6 months

The outcomes necessary to respond to the secondary objective are the administration of the following test:

fecal calprotectin (mg/kg)

6 months
The secondary outcome will be to describe and evaluate the impact of the nutritional intervention by describing the changes in some Inflammatory markers
Time Frame: 6 months
The outcomes necessary to respond to the secondary objective are the administration of the following Inflammatory markers: IL-6 and IL-1β values (pg/ml)
6 months
The secondary outcome will be to describe and evaluate the impact of the nutritional intervention by describing the changes in measurement of proteins
Time Frame: 6 months
The outcomes necessary to respond to the secondary objective are the administration of the following measurement of proteins: C-reactive protein values (mg/dL)
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Barbara Gardella, Dott, IRCCS Policlinico San Matteo

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2020

Primary Completion (Anticipated)

December 30, 2023

Study Completion (Anticipated)

December 30, 2023

Study Registration Dates

First Submitted

January 24, 2022

First Submitted That Met QC Criteria

May 18, 2022

First Posted (Actual)

May 24, 2022

Study Record Updates

Last Update Posted (Estimate)

May 11, 2023

Last Update Submitted That Met QC Criteria

May 10, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2021-ENDODIET

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Endometriosis

Clinical Trials on Nutritional intervention

Subscribe